Lymphoma Foundation Research Grants - Deadline Sept 10th

1 post / 0 new
Guest (not verified)
Guest's picture
Lymphoma Foundation Research Grants - Deadline Sept 10th

Grants and Awards: Advancing the Cutting Edge
Funding fuels clinical research, the vital engine that drives progress in the treatment of lymphoma. Through research, clinicians and scientists are constantly learning more about the causes of cancer and its development. Each advance in understanding brings new ideas for ways to combat the disease. New treatments result from multiple phases of clinical testing, starting in a Petri dish (where lymphoma cells can be cultured and exposed to possible therapeutic agents), then in animals, and finally in human beings. It is a long, difficult, and expensive process.

www.lymphoma.org/research/grants

LRF is proud to have funded more than $35 million in lymphoma research as of the close of FY 2007 in the U.S., Canada, and Europe.

Learn about some of the talented researchers who have received LRF funding, and their projects.

GRANTS NOW AVAILABLE!
Applications are currently available for LRF's Research Program. The deadline for submitting applications is September 10, 2008. Applications will be peer-reviewed, and applicants will be notified of results by March 2009.

LRF is currently accepting applications for:

2-Year Post-Doctoral Fellowships
3-Year Clinical Career Development Awards
3-Year Follicular Lymphoma R01-Type Grants*
3-Year Follicular Lymphoma Correlative Clinical Study Awards*
*NOTE: A letter of intent is required for both of the Follicular Lymphoma grants and is due August 1, 2008.

All applications must be submitted electronically. To apply for these grant opportunities, please go to https://proposalcentral.altum.com

For more information, please call: 800-235-6848

Future Funding Opportunities

LRF is currently fundraising to support additional grants in the following areas. Visit the website later this year for possible new grant announcements.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Mantle Cell Lymphoma (MCL) Initiative Grants
Mantle Cell Lymphoma Correlative Grants
Engaging and Educating Junior Researchers
Post-Doctoral Fellowships and Clinical Investigator Career Development Awards are central to our mission and represent our two Cornerstone Research Programs. These programs attract young physicians to the field of lymphoma and support their training in lymphoma and clinical research. The National Institutes of Health (NIH) and National Cancer Institute (NCI) cite the training of clinical investigators and translational researchers in their Roadmap for how to improve health and alleviate suffering from disease. The Lymphoma Research Foundation shares this priority. The LRF is proud that since 1992 we have awarded 208 Fellowships, while since 2002, we have awarded 11 Clinical Career Development Awards.

Post-Doctoral Fellowships
These two-year fellowships help attract the nation's best scientific talent to careers in lymphoma and allow them to pursue promising leads under the guidance of a Sponsor. Applicants must be affiliated with an institution in the U.S. or Canada. Up to 10 fellowships may be awarded, each at $50,000 in year one, and $55,000 in year two.

Fellowship Guidelines
Fellowship Policy, Terms and Conditions

Back to List

Clinical Investigator Career Development Awards (CDAs)
This three-year program (now with recently expanded eligibility) funds training of clinicians who will participate in developing new therapeutics and diagnostic tools for lymphoma. Clinicians will be trained to design and administer clinical studies and to take on primary responsibility for trial design, protocol development, IRB submission, and publication. A Career Development Plan and the commitment of a mentor are required as part of the grant application. Up to three CDAs will be awarded, each at a maximum of $75,000 per year for three years. Applicants must be licensed in the U.S. or Canada.

Career Development Guidelines
Career Development Policy, Terms and Conditions

Back to List

Focus Areas
Major Research Grants for Senior Researchers: These are awarded to experienced researchers pursuing the development of novel and innovative treatments.

Follicular Lymphoma
The goal of LRF's Follicular Lymphoma (FL) Research Initiative is to develop novel therapeutic strategies for the treatment of FL. LRF is seeking proposals that advance the understanding of the human biology of FL or that verify molecular targets for FL therapeutics. LRF is awarding two grants for this special research initiative, each at a maximum of $250,000 per year for three years.

Follicular Lymphoma RO1-Type Grant Guidelines
Follicular Lymphoma R01-Type Grant Policy, Terms & Conditions

Back to List

Follicular Lymphoma Correlative Clinical Studies Award
LRF is also seeking proposals for correlative clinical studies in follicular lymphoma (FL). Applications to this initiative must be adjunct to a major FL research project and work in the clinical setting or with primary FL patient samples. LRF is awarding two correlative clinical study awards, each at a maximum of $125,000 per year for three years.

Follicular Lymphoma Correlative Studies Award Guidelines
Follicular Lymphoma Correlative Studies Award Policy, Terms & Conditions

Back to List

Future Funding Opportunities: LRF is currently fundraising to support additional grants in the following areas. Visit the website later this year for possible new grant announcements.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
This LRF initiative (started in 2006) aims to develop novel therapeutic strategies for the treatment of CLL/SLL by funding projects that advance the understanding of the human biology of this disease and/or that verify molecular targets for CLL/SLL therapeutics. In 2006-2007, funding was available for up to three years, for a maximum of $250,000 per year plus overhead (up to 25%). Future CLL/SLL grant opportunities are dependent on the availability of funds. Please visit the website later this year for possible new grant announcements in this focus area.

Mantle Cell Lymphoma (MCL)
In 2003, LRF started the Mantle Cell Lymphoma Initiative to accelerate the pace of research in mantle cell lymphoma (MCL). LRF-funded MCL research projects have ranged from laboratory studies to the identification of new therapeutic approaches, including clinical trials of novel agents, chemo immunotherapy, radiation therapy and stem cell transplantation. Previously, funding for this initiative has been up to $250,000 plus overhead (up to 25%), for up to three years duration. International applications from licensed researchers were accepted. Future MCL grant opportunities are dependent on the availability of funds. Please visit the website later this year for grant announcements in this focus area.

Back to List

Requests for further information should be directed to eval(unescape('%64%6f%63%75%6d%65%6e%74%2e%77%72%69%74%65%28%27%3c%61%20%68%72%65%66%3d%22%6d%61%69%6c%74%6f%3a%72%65%73%65%61%72%63%68%67%72%61%6e%74%73%40%6c%79%6d%70%68%6f%6d%61%2e%6f%72%67%22%3e%72%65%73%65%61%72%63%68%67%72%61%6e%74%73%40%6c%79%6d%70%68%6f%6d%61%2e%6f%72%67%3c%2f%61%3e%27%29%3b')).

NOTE: Lymphoma Research Foundation reserves the right to change deadlines, forms, and guidelines, plus any and all details pertaining to grant availability, rules, eligibility criteria, selection process, etc. All LRF Research Grants are dependent on funding availability.

CLINICAL TRIALS
To learn more about participation in clinical trials, click here.
To access a database of clinical trials for Mantle Cell Lymphoma, click here.

If you would like to learn more about how you can invest in lymphoma research, please contact 800-235-6848